A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
Public ClinicalTrials.gov record NCT01328626. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01328626
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 222 participants
Conditions and interventions
Conditions
Interventions
- ABT-199 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2011
- Primary completion
- May 7, 2020
- Completion
- May 7, 2020
- Last update posted
- Feb 22, 2022
2011 – 2020
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona Cancer Center - North Campus /ID# 52902 | Tucson | Arizona | 85719-1478 | — |
| Ucsd /Id# 48325 | La Jolla | California | 92093 | — |
| Dana-Farber Cancer Institute /ID# 48324 | Boston | Massachusetts | 02215 | — |
| Memorial Sloan Kettering Cancer Center /ID# 56810 | New York | New York | 10065-6007 | — |
| University of Texas MD Anderson Cancer Center /ID# 48326 | Houston | Texas | 77030 | — |
| Swedish Medical Center /ID# 135853 | Seattle | Washington | 98104 | — |
| Fred Hutchinson Cancer Research /ID# 52882 | Seattle | Washington | 98109 | — |
| Univ of Wisconsin Hosp/Clinics /ID# 56811 | Madison | Wisconsin | 53792-0001 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01328626, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01328626 live on ClinicalTrials.gov.